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Introduction: MicroRNA (miRNA) are small, non-coding RNA that act post-
transcriptionally to regulate gene expression. miRNA levels are modulated by 
acute aerobic exercise, yet little is known about how miRNA levels may change 
in response to high-intensity interval exercise. Further, almost nothing is known 
about the impact of post-exercise nutrition (carbohydrate and/or protein) on 
miRNA levels. Thus, the purpose of this study is to examine the effects of high-
intensity interval cycling and different post-exercise nutrients on ci-miRNA levels. 
Methods: Nine recreationally active males (age 21.9 ± 2.0yrs; VO2max 49.6 ± 
4.0mL/kg/min) competed three trials, each including identical exercise protocols. 
Protocol involved two Wingate tests separated by four sets of high-intensity (3 
minutes @ 90% Wmax separated by 1 minute @ 50% Wmax) intervals, along with 
warm-up and cooldown. Finger stick and venous blood samples were collected 
pre- and up to four hours post-exercise. Additionally, a different nutrition 
treatment (i.e. carbohydrate, carbohydrate + protein, or control) was administered 
immediately post-exercise. Serum samples were analyzed for content of twelve 
target miRNA (miR-1, -21, -126, -133a, -146a, -150, -206, -210, -221, -222, -486, 
and -499). miRNA levels were expressed as fold changes relative to baseline of 
1 and paired-samples t-tests and post hoc two-way, repeated measures 
ANOVAs were used to detect changes in miRNA levels across chosen timepoints 
and treatments. Results: miR-210 and miR-486 were unaffected by exercise at 
any timepoints and all remaining targets were either unchanged or upregulated 





baseline at four-hours post-exercise. Nutrition only affected miR-150, 
downregulating it at one-hour post-exercise. Post hoc analysis revealed a main 
effect for time for all targets immediately post-exercise. Further, a main effect for 
time was observed one-hour post-exercise for miR-1 and miR-210 and at four 
hours pos-exercise for miR-210 and mIR-146a.  Conclusion: High-intensity 
cycling impacted miRNA implicated in skeletal and cardiac phenotype, 
angiogenesis, and inflammation, though post-exercise nutrition was 
inconsequential except for miR-150. It is currently unknown the extent to which 
intracellular miRNA activity may be reflected in circulation, thus further work is 















Epigenetics is a field of study focused on how lifestyle and environmental 
factors can alter gene expression. The role that microRNA (miRNA) has in 
modulating gene expression is of growing interest.  miRNA are small (˜22 
nucleotides in length), noncoding RNA that degrade specific mRNA (i.e. post-
transcriptional regulation) as a strategy to decrease the probability of protein-
specific translation.  miRNA are encoded in the genome and transcribed in the 
nucleus by RNA polymerase II to produce a primary RNA transcript (pri-miRNA) 
(1). A pri-miRNA typically consists of a stem, approximately 33-35 base pairs in 
length, and a terminal loop structure (2). Upon cleavage by a complex consisting 
of the Drosha enzyme (3) and the Di George Syndrome critical region 8 protein 
(DGCR8) (4), the pri-miRNA is converted into a pre-miRNA, which is exported 
into the cytoplasm of the cell via the Exportin 5 protein (5). The pre-miRNA is 
further cleaved by the Dicer enzyme, producing a mi-RNA duplex. The duplex is 
split, at which point the mature miRNA strand binds with an argonaute protein (6) 
to form the RNA-induced silencing complex (RISC). This RISC assembly is able 
to modulate protein translation by binding to target messenger RNA (mRNA) and 





Figure 1A. miRNA Biogenesis 
 
(A) miRNA is transcribed from coding gene in the nucleus by RNA polymerase II, producing pri-miRNA. (B) pri-
miRNA gets cleaved by Drosha/Di George Syndrome critical region gene 8 (DGCR8) complex, producing pre-miRNA. (C) 
pre-miRNA exits the nucleus into the cytoplasm via Exportin-5 protein. (D) pre-miRNA is cleaved by Dicer protein, 
producing miRNA/miRNA duplex. (E) Duplex splits, with one half being discarded (F), and the other half being bound to its 
corresponding argonaute protein (ARG) to form the miRNA-induced silencing complex (RISC) (G). (H) RISC enters into 
circulation, via passive leak or active release in extracellular vesicles. (I) RISC is brought into neighboring cell, where it 





 Initially discovered in 1993 in C. elegans (7), there are now 2,588 
documented miRNA found in humans (8). While originating within the cell, 
miRNA have recently been found in the circulation, as a result of passive leak 
through the cell membrane or active secretion in extracellular vesicles (9–11), 
expanding their potential for use as mechanisms of intercellular communication 
(12, 13), or biomarkers of cellular injury or disease (14, 15). A single miRNA can 
regulate multiple sets of different mRNA (16), suggesting the potential for miRNA 
to have widespread influence on mRNA translation. Importantly, miRNA 
expression is cell-type specific (17) . McCarthy detailed a set of muscle-specific 
miRNA named ‘myomiRs’ , consisting of miR-1, miR-133a, miR-206, miR-208a, 
miR-208b, miR-486, and miR-499, which are believed to have a major role in 
skeletal muscle fiber type (18). Moreover, earlier work by the McCarthy lab 
demonstrated downregulation of miR-208b and miR-499 activity during skeletal 
muscle atrophy, which was associated with depression of beta-myosin heavy 
chain (β-MHC) protein (19). Furthermore, knockout studies in rodent models 
suggest these miRNA may also impact muscle mass via downregulation of 
myostatin expression, allowing for increased muscle growth (20). Finally, 
Yamakuchi described a group of miRNA involved in vascular development and 
homeostasis, as well as endothelial cell senescence (21). These studies suggest 
that groups of miRNA interact to regulate or modulate a multitude of physiological 
processes. 
 





While acute exercise perturbs homeostasis, repeated exposure to acute exercise 
(i.e. training) can evoke favorable changes in phenotype such as increased 
muscle mass, aerobic capacity, and capillary growth (22–24). A better 
understanding of the molecular events that elicit adaptations to exercise has the 
potential to instruct interventions to improve health, performance, and quality of 
life. Because of the relatively new discovery of miRNA, and its presence in 
circulation, very little is understood about the behavior of miRNA following 
exercise and how miRNA may therefore affect adaptations. The influence of 
acute exercise on circulating miRNA (ci-miRNA) levels was detailed by Banzet et 
al. who reported that plasma miRNA were elevated in the early hours following 
30 minutes of walking (25). Not only did an acute session of walking alter miRNA 
levels but also the response was specific to the type of walking. Downhill walking, 
which accentuates eccentric muscle contractions, elicited an increase in muscle-
enriched myomiRs (miR-1, 133a, 133b, and 208b) that have been shown to 
influence myocyte differentiation (26). Alternatively, uphill walking led to an 
increase in miR-181b and miR-214. The idea that miRNA levels are mediated in 
a contraction type-specific or mode-specific manner was extended by Uhlemann 
et al. miRNA levels following different doses of aerobic exercise (incremental 
max test vs. 4 hours of cycling vs. marathon footrace) were compared to the 
response to eccentric resistance exercise. ci-miR-126 was elevated in each dose 
of aerobic exercise and miR-133 was elevated following the marathon race and 
the eccentric resistance exercise (27). This study helped demonstrate both 





evidence for the effect of exercise dose on ci-miRNA response was found 
following different doses of acute aerobic exercise (10-km or marathon).  
Distinctly different inflammatory ci-miRNA patterns were observed between both 
distances, suggesting the potential use of ci-miRNA as biomarkers for 
inflammation (28). 
 
   In addition to the transient changes in miRNA following different types of 
acute exercise, several studies have revealed that basal and post-exercise ci-
miRNA is influenced by training status. Specifically, there were higher levels of 
cardiovascular and inflammatory miRNA in endurance-trained athletes compared 
to resistance-trained athletes (29). A subsequent investigation demonstrated that 
training can modulate miRNA, as miR-486 was lower following acute cycling and 
4 weeks of cycle training (30). More specifically, 6 weeks of endurance training 
downregulated miRNA that target mRNA known to code for various transcription 
factors, which in turn led to the upregulation of these transcription factors (31). 
Importantly, miRNA may serve as useful indicators of the potential for individuals 
to respond to training programs. Davidsen et al. observed differential changes in 
several miRNA following a 12-week resistance training program. miRNA-451 was 
upregulated in “high responders” to the training while miR-26a, miR-29a, and 
miR-378 were downregulated in “low responders” and unchanged in the higher 
responders (32). Taken together these data may provide mechanistic insight into 






High intensity interval training (HIIT) is an increasingly popular form of 
aerobic exercise partly due to its time efficient nature. HIIT is characterized by 
short intervals (30 seconds to 4 minutes) of high-intensity work coupled with 
lower intensity recovery intervals. HIIT has been shown to improve aerobic 
capacity and body composition (33, 34) at magnitudes similar to continuous 
aerobic training, but with much less training volume (35, 36). Gillen and Gibala 
have proposed that as little as 3 HIIT sessions per week, with <10 min of high 
intensity per session, may produce favorable adaptations in aerobic capacity, 
muscle oxidative capacity, and exercise tolerance (37). HIIT has also been 
shown to greatly improve skeletal muscle fat and carbohydrate oxidative 
capability (38), even in as few as seven sessions over two weeks (39). 
Additionally, mitochondrial content and biogenesis have been demonstrated to 
increase following HIIT, providing physiological evidence for improved peripheral 
oxygen extraction (40, 41). Finally, HIIT has been shown to improve insulin 
sensitivity (34) and promote muscular hypertrophy (42), demonstrating a wide 
array of health benefits.  
 
Despite the recent attention to HIIT, little is known about the impact of 
high-intensity exercise on post-exercise miRNA response, as only a few studies 
have used a high-intensity exercise mode to profile miRNA levels. While low-
volume sprint interval cycling (2 x 30 sec at maximum effort, separated by 4 min 
active recovery) in healthy, adult males has been shown to influence ci-miRNA 





interval running (7 x 4 min at 85 - 95% HRmax) and distance-matched, 
continuous running (44). Additionally, further research is needed to illustrate the 
time-course of the miRNA response following high-intensity exercise, as neither 
of the previously mentioned studies collected blood samples past the immediate 
post-exercise period. This is a major limitation due to the fact that ci-miRNA 
levels have been shown to fluctuate in the hours following acute exercise (45).  
 
  Post-exercise carbohydrate (CHO) and protein (PRO) intake can impact 
the molecular response to exercise (46). Specifically, acute post-exercise protein 
consumption has been shown to improve net protein balance following both 
resistance and endurance exercise (47, 48). Furthermore, the inclusion of protein 
in a post-exercise carbohydrate supplement has a positive effect on skeletal 
muscle transcriptome response to endurance exercise (49). While studies have 
repeatedly demonstrated the benefits of post-exercise nutrient consumption, 
virtually nothing is known about the effects of different nutritional interventions 
post-exercise on miRNA levels. Drummond et al. observed an increase in several 
muscle-enriched miRNA (miR-1, miR-23a, miR-208b, and miR-499, as well as 
pri-miR-206) following the consumption of 10 g of essential amino acids (EAA), 
but without any exercise intervention (50). Perhaps more applicable to the 
proposed study, Camera et al. demonstrated increase of several miRNA 
implicated in exercise adaptation (increase of miR-23a, miR-23b, miR-133b, miR-
181, and miR-378 with a decrease of miR-494) with PRO ingestion following 





post-exercise in the placebo treatment, but following protein consumption post-
exercise, remained unchanged. The target genes for several of these miRNA are 
involved in translation initiation and muscle protein synthesis, suggesting a 
regulatory potential for miRNA in the formation of proteins vital to exercise 
adaptation (51). More importantly, the aforementioned data provide preliminary 
evidence that nutrient intake can impact miRNA. To our knowledge, nothing is 
known about how carbohydrate influences the post-exercise miRNA response. 
The goal of this study is to characterize the effects of HIIT and different post-

















Aims and Hypotheses 
 
Aim 1: To profile ci-miRNA implicated in skeletal muscle or cardiovascular 
function, angiogenesis, or inflammation immediately, 1 hour, and 4 hours 
following high intensity interval cycling.  
Hypothesis 1: High-intensity interval cycling will increase muscle, cardiovascular, 
and inflammatory miRNA in circulation post-exercise, and levels will remain 
elevated in the four hours following exercise. 
 
Aim 2: To investigate the potential impact of different post-exercise nutrition 
treatments on miRNA expression observed in circulation. 
Hypothesis 2: Post-exercise carbohydrate + protein will decrease ci-miRNA 
profiles for muscle-enriched miRNA compared to non-nutritive placebo, but will 
have no influence on other target miRNA. Additionally, carbohydrate will have 













   miRNA are now understood to influence a wide array of physiological 
processes (13, 18, 52). While research has examined how miRNA levels are 
altered in disease states (14, 53), less research has been focused on the effect 
of exercise on modulation of miRNA levels. While exercise has shown a dose 
(27) and mode-dependent (28) influence on miRNA found in circulation, few 
studies have specifically investigated the effects of HIIT on miRNA.  
  High-intensity interval training (HIIT) is an increasingly popular form of 
exercise due to its high efficiency. HIIT has been shown to produce similar 
improvements in aerobic capacity as continuous aerobic exercise (33), but with 
significantly less training volume required (35). Furthermore, HIIT has been 
shown to improve body composition and insulin sensitivity (33, 34), suggesting its 
efficacy for both healthy and clinical populations. While low-volume HIIT has 
been shown to alter miRNA levels (43), no miRNA measurements were taken 
beyond the immediate post-exercise period, leaving the time-course for miRNA 
return to baseline following HIIT largely unexplored.   
While studies have examined the impact of protein consumption, with and 
without exercise, on miRNA patterns (50, 51), the impact of carbohydrate on 
miRNA has yet to be explored. This study provides a unique opportunity to 
examine the effects of carbohydrate, separate from and in conjunction with 
protein. Since post-exercise nutrition is understood to influence the transcriptome 






























Subject Recruitment  
Nine recreationally active, healthy males will be recruited via word of 
mouth, flyers, and email from James Madison University and the Harrisonburg 
area. All subjects will be nonsmokers and cleared for participation of vigorous 
exercise, according to ACSM guidelines. Based on ACSM guidelines, people are 
approved for vigorous exercise if they are without signs, symptoms, or diagnosis 
of cardiovascular, metabolic, or renal disease (54). All procedures will be 
approved by the James Madison University Institutional Review Board. 
VO2max Testing 
Upon obtaining informed consent, height, and weight, subjects will 
undergo a graded exercise test to determine maximal aerobic capacity (VO2max). 
Testing will be performed on an electronically braked cycle ergometer (Velotron 
Inc. Seattle, WA). Subjects will begin the test at a self-selected workload 
described as “comfortable, but not easy pace for a 1-hour ride”. Workload will 
increase by 25W every 60 seconds until volitional fatigue or failure to maintain a 
minimum cadence of 50 rpm. Oxygen uptake will be measured throughout the 
test via Moxus (Pittsburgh, PA, USA) or Vmax®Encore PFT (Vyaire Medical Inc, 
Yorba Linda, CA) metabolic cart and the maximum wattage (Wmax) obtained 





protocols. Heart rate (HR) and rate of perceived exertion (RPE) will be assessed 
during the last 15 seconds of each stage. 
Exercise Trials 
Exercise Protocols 
Exercise procedures are detailed below (Figure 1). Subjects will perform 
three experimental trials consisting of identical exercise protocols with three 
different post-exercise nutrient conditions. Following a 5-minute warm up at a 
workload of 50 watts, subjects will complete an interval cycling protocol 
consisting of a 30 second, maximal effort sprint (Wingate test), 4 sets of 3 
minutes cycling at 90% Wmax (with 1 minute of cycling at 50% Wmax between 
intervals), and a second Wingate test. Subjects will recover for 3 minutes 
between the first Wingate test and the intervals, and 1 minute between the 
intervals and the second Wingate test. Following post-exercise blood sampling, a 
5-minute cooldown at a self-selected workload will be performed. The workload 
during the cooldown will be recorded and replicated in each subsequent trial. 
Heart rate will be obtained during the final 30 seconds of each interval (Polar; 
Lake Success, NY, USA). 
Nutrition Treatments 
Following exercise, subjects will receive one of the following treatments: 





CHO: matched for CHO-content in CHO+PRO treatment (approximately 
65 g) mixed in 20 oz water (CLIF Bar & Company, Emeryville, CA) 
PLA: 20 oz water 
The treatments will be consumed within 30 minutes of exercise completion. The 
amount of time taken to consume the beverage during the initial trial will be 
replicated across all exercise trials.   
 
Blood Samples 
Venous blood samples will be obtained pre-exercise, immediately post-
exercise, 1-hour post-exercise, and 4 hours post-exercise. Samples will sit at 
room temperature for 30-45 minutes to allow clotting. Samples will be centrifuged 
at 4°C for 15 minutes at 1500 rcf and 500 µL aliquots of serum will be pipetted. 
The aliquoted serum will be stored at -80°C in the Human Performance Lab at 
James Madison University for the duration of data collection. Upon completion of 
data collection, samples will be sent to the University of Maryland for miRNA 
quantification analysis. The following miRNA will be measured: 
  Skeletal muscle: 1, 133a, 206, 486, 499 
Cardiovascular: 21, 126, 150, 210 
Inflammation: 146a, 221, 222 
Furthermore, hematocrit will be measured at each sample timepoint via 





mathematically correct for hydration status. In addition to venous blood samples, 
finger stick blood samples will be obtained pre-exercise and every 30 minutes 
post-exercise for 4 hours to measure blood glucose levels. Blood glucose levels 
will be measured via YSI 2900 Series Analyzer (YSI Inc. Yellow Springs, OH).  
 Standardization Procedures 
Subjects will report to the laboratory between 5:30-9am following an 
overnight fast. They will be instructed to refrain from tobacco or alcohol 
consumption or exercise for 24 hours pre-trial and refrain from caffeine 
consumption for 12 hours pre-trial. Subjects will be asked to record dietary intake 
for 24 hours and physical activity for 72 hours before the trials. They will be given 
copies of their dietary and physical activity logs and asked to replicate them 
between trials. Subjects will receive a small, standardized meal 2 hours post-
exercise (90 minutes post-treatment beverage). 
Statistical Analysis 
Changes in ci-miRNA will be reported as fold changes. Magnitude-based 
inferences about the data will be derived using methods described by Hopkins 
and colleagues (55, 56). The threshold value for a substantial treatment effect 
will be defined as 0.2 x within-subject standard deviation, under resting 
conditions. 
Published spreadsheets (57) will be used to determine the likelihood of the 
true treatment effect (of the population) reaching the substantial change 





chance, 1-5% = very unlikely, 5-25% = unlikely, 25-75% = possible, 75-95% = 
likely, 95-99% = very likely, and >99% = almost certain. Clinical inference criteria 
will be used to classify the effects of condition on performance. Specifically, if the 
percent chance of the effect reaching the substantial change threshold is <25% 
and the effect is clear, it will be classified as ‘trivial’. If the percent chance of the 
effect reaching the substantial change threshold for benefit exceeds 25% but the 
chance for harm is >0.5% the effect will be classified as unclear. An exception to 
the 0.5% chance of harm criterion will be made if the benefit/harm odds ratio is 
>66, in which case the effect will be interpreted as clear and an inference was 
assigned.   
Separate analyses will be performed on each nutritional intervention (PLA, 
CHO, CHO + PRO) using the spreadsheet mentioned above (57). The outcomes 
from each condition will be compared using the same spreadsheet (57). The 
classification system detailed above will be applied but mechanistic criteria will 
be used such that if 90% confidence intervals include values that exceed the 
substantial change threshold for both a positive and negative effect, effects will 
be classified as unclear (>5% chance of reaching the substantial threshold for 































Circulating MicroRNA Following High Intensity Interval Cycling With and 
Without Post-Exercise Nutrient Consumption 
Authors: Jeremy O. Via1, Ryan M. Sapp2, Daniel D. Shill2, Katherine R. Smith1, 
Shane A. Chambers1, Michael J. Saunders1, Christopher J. Womack1, James M. 
Hagberg2, and Nicholas D. Luden1 
Institutions: 1James Madison University, Harrisonburg, VA 22807, 2University of 
Maryland, College Park, MD 20742 
Contacts: Jeremy O. Via, viajo@dukes.jmu.edu 
  Ryan M. Sapp, rsapp@umd.edu  
  Daniel D. Shill, dshill@umd.edu  
  Katherine R. Smith, smith4kr@dukes.jmu.edu  
  Shane A. Chambers, chamb2sa@dukes.jmu.edu  
Michael J. Saunders, saundemj@jmu.edu 
Christopher J. Womack, womackcx@jmu.edu  
James M. Hagberg, hagberg@umd.edu  









Introduction: MicroRNA (miRNA) are small, non-coding RNA that act post-
transcriptionally to regulate gene expression. miRNA levels are modulated by 
acute aerobic exercise, yet little is known about how miRNA levels may change in 
response to high-intensity interval type exercise. Further, almost nothing is known 
about the impact of post-exercise nutrition (carbohydrate and/or protein) on miRNA 
levels. Thus, the purpose of this study is to examine the effects of high-intensity 
interval cycling and different post-exercise nutrition treatments on ci-miRNA levels. 
Methods: Nine recreationally active males (age 21.9 ± 2.0yrs; VO2max 49.6 ± 
4.0mL/kg/min) competed three trials, each consisting of the same exercise 
protocol. Protocol consisted of two Wingate tests separated by four sets of high-
intensity (3 minutes @ 90% Wmax separated by 1 minute @ 50% Wmax) along with 
warm-up and cooldown. Finger stick and venous blood samples were collected 
pre- and up to four hours post-exercise. Additionally, a different nutrition treatment 
(i.e. carbohydrate, carbohydrate + protein, or control) was administered 
immediately post-exercise. Serum samples were analyzed for content of twelve 
target miRNA (miR-1, -21, -126, -133a, -146a, -150, -206, -210, -221, -222, -486, 
and -499). miRNA levels were expressed as fold changes relative to baseline of 1 
and paired-samples t-tests and post hoc two-way, repeated measures ANOVAs 
were used to detect changes in miRNA levels across chosen timepoints and 
treatments. Results: Two targets (miR-210 and miR-486) were unaffected by 
exercise at any timepoints and all remaining targets were either unchanged or 





to baseline at four-hours post-exercise. Nutrition only affected miR-150, 
downregulating it at one-hour post-exercise. Post hoc analysis revealed a main 
effect for time for all targets immediately post-exercise. Further, a main effect for 
time was observed one-hour post-exercise for miR-1 and miR-210 and at four 
hours pos-exercise for miR-210 and mIR-146a.  Conclusion: High-intensity 
cycling impacted miRNA implicated in skeletal and cardiac phenotype, 
angiogenesis, and inflammation, though post-exercise nutrition was found to be 
inconsequential for all targets except miR-150. It is currently unknown the extent 
to which intracellular miRNA activity may be reflected in circulation, thus further 
















Repeated exposure to acute exercise elicits phenotype changes that lead 
to improvements in health and performance. Post-exercise alterations in the 
availability of messenger RNA (mRNA) for translation into protein is one of the key 
mechanisms that facilitates these adaptations. mRNA availability is regulated by 
both gene transcriptional activity (i.e. gene to mRNA) and alterations to mRNA 
following transcription. The latter is believed to be predominantly mediated by 
small (~20-24 nucleotides) non-coding microRNA (miRNA). Upon maturation, 
miRNA and argonaute proteins (Ago) form RNA-induced silencing complex (RISC) 
that targets mRNA and, through silencing or degradation, downregulate mRNA 
translation to protein (1, 6). A single miRNA can have multiple target mRNA, 
allowing for miRNA to have widespread influence on protein-specific synthesis 
(16). Not only have certain miRNA been generally associated with certain types of 
cancer (58), obesity (59), diabetes (60), and cardiovascular disease (61), there is 
clear evidence that manipulating miRNA levels can directly impact phenotype. 
Among many other possible examples, the skeletal muscle-specific suite of miRNA 
(myomiRs) are now believed to play an integral role in skeletal muscle fiber type, 
as overexpression of miR-499 in the mouse soleus was shown to induce 
conversion of all fast myofibers to slow myofibers (18). Further, knockout of miR-
126, a proangiogenic miRNA, promoted leukocyte adherence to endothelial cells 
via decreased inhibition of vascular cell adhesion molecule-1 (VCAM-1) (62).   
Though miRNA were first discovered intracellularly, miRNA are also present 





miRNA could facilitate intercellular communication and, more practically, providing 
easier access for the study of miRNA (63). ci-miRNA originate from host tissues 
and enter circulation packaged in microvesicle exosomes (10), high density 
lipoproteins (64), or bound to argonaut transport proteins (65). The extent and 
control of cell specific targeting and miRNA sorting/packaging for export is 
currently unknown. However, the parent cell miRNA is ultimately transported and 
taken up by target cells whereby the parent miRNA exerts an endogenous-like 
miRNA effect (64). Like intracellular miRNA, ci-miRNA are also associated with a 
variety of diseases (66) and are sensitive to environmental stressors such as 
exercise (67), altogether indicating that the miRNA response to exercise probably 
plays a role in adaptations to exercise training. 
 It is clear that exercise modulates levels of certain miRNA and that these 
changes are influenced by contraction type (25), exercise mode (27), and dose 
(28), Of the little that is known about how exercise influences ci-miRNA, virtually 
all has been documented following traditional aerobic and resistance type 
exercise. High intensity interval training (HIIT) is an increasingly popular form of 
exercise.  This is due to the combination of its time efficient nature (30-second to 
4-minute intervals of high-intensity work coupled with lower intensity recovery 
intervals) and favorable adaptations (i.e. improved aerobic capacity (37), 
mitochondria content (40), abdominal fat loss (34), and improved fat oxidation 
(38)). Despite the recent attention to HIIT, little is known about the impact of high-
intensity exercise on the post-exercise miRNA response. There is some evidence 





miRNA (43, 44). However, the targets in these studies were almost all muscle-
specific; thus, further research is warranted to examine the effects of high-intensity 
exercise on miRNA of other tissues.  
Despite the fact that post-exercise nutrition can influence recovery and 
adaptation to exercise, the influence that post-exercise nutrient uptake may have 
on mi-RNA levels has been largely overlooked. Post-exercise carbohydrate (CHO) 
and protein (PRO) intake can impact the molecular responses to exercise (46). 
Acute post-exercise PRO ingestion can improve net protein balance following both 
resistance (47) and aerobic exercise (48). Further, the addition of PRO to a post-
exercise CHO supplement has a positive effect on the skeletal muscle 
transcriptome response to endurance exercise (49). However, few studies have 
investigated the impact of different post-exercise nutritional interventions on ci-
miRNA levels. The consumption of 10 g of essential amino acids, absent any 
exercise, increases several muscle-enriched miRNA in muscle biopsy samples 
(50). Likewise, PRO ingestion following concurrent resistance and exercise 
enhances several miRNA implicated in exercise adaptations (51). While PRO 
consumption can alter miRNA activity, to our knowledge, nothing is known about 
how PRO influences miRNA in combination with high-intensity exercise, 
particularly ci-miRNA. Additionally, nothing is known about how CHO impacts post-
exercise ci-miRNA. Therefore, the purpose of this study is to explore the effects of 
high-intensity interval cycling and different post-exercise nutrition composition on 
circulating profiles for miRNA implicated in skeletal and cardiac muscle plasticity, 







Fifteen recreationally active, healthy adult males were recruited from James 
Madison University and the surrounding area. Six subjects withdrew from the study 
due to scheduling difficulties and other factors not related to the project. Therefore, 
complete data were obtained on nine subjects. Subject demographics are reported 
in Table 1. All procedures were approved by the James Madison University 
Institutional Review Board.  
Physical Activity and Diet Standardization Procedures 
Subjects reported to the laboratory between 5:30-9:00 am following an overnight 
fast. To standardize pre-fast dietary intake, all subjects were provided nutrition 
shakes (Ensure, Abbott Laboratories, Shawnee, KS) equivalent to 20% of daily 
resting energy expenditure, as estimated via the Harris-Benedict equation (68).  
They were instructed to refrain from tobacco, alcohol consumption, or exercise for 
24 hours pre-trial and refrain from caffeine consumption for 12 hours pre-trial. 
Subjects recorded dietary intake for 24 hours and physical activity for 72 hours 
before the trials. They were provided with copies of their dietary and physical 
activity logs and asked to replicate them between trials. Subjects also consumed 
a small, standardized meal (440 calories, 3 g fat, 93 g carbohydrate, 10 g protein) 








Subjects performed a graded exercise test to determine maximal aerobic 
capacity (VO2max). Testing was performed on an electronically-braked cycle 
ergometer (Velotron Inc. Seattle, WA). Subjects began the test at a self-selected 
workload described as a “comfortable, but not easy pace for a 1-hour ride”. 
Workload was increased by 25 W every 60 seconds until volitional fatigue or 
cycling cadence dropped below 50 rpm. Oxygen uptake was measured throughout 
the test via Moxus (Pittsburgh, PA, USA) or Vmax®Encore PFT (Vyaire Medical 
Inc, Yorba Linda, CA) metabolic cart and the maximum wattage (Wmax) obtained 
during the VO2max test was used to assign work rates for the exercise protocols. 
Heart rate (HR) and ratings of perceived exertion (RPE) were assessed during the 
last 15 seconds of each stage. 
Subjects performed three experimental trials consisting of identical exercise 
protocols with three different post-exercise nutrient conditions (Figure 1). Following 
a 5-minute warm up at a workload of 50 watts, subjects completed an interval 
cycling protocol consisting of a 30 second, maximal effort sprint (Wingate test), 4 
sets of 3 minutes cycling at 90% Wmax (with 1 minute of cycling at 50% Wmax 
between intervals), and a second Wingate test. Subjects recovered for 3 minutes 
between the first Wingate test and the intervals, and 1 minute between the intervals 
and the second Wingate test. Following post-exercise blood sampling, a 5-minute 
cooldown at a self-selected workload was completed. The workload during the 





trial. Heart rate was obtained during the final 30 seconds of each interval (Polar; 
Lake Success, NY, USA). 
Nutrition Treatment 
Following exercise, subjects consumed one of the following treatments 
within 30 minutes following exercise (consumption finish time was repeated across 
trials) in a randomized, counterbalanced order:  
- Carbohydrate + Protein; ~600 ml of Chocolate Milk (Great Value, Dean 
Foods, Dallas, TX) containing 65g carbohydrate and 20g protein 
- Carbohydrate; ~600 ml of water with added chocolate flavored CLIF Bar 
gel to match the carbohydrate content of the Carbohydrate + Protein 
treatment (CLIF Bar & Company, Emeryville, CA) 
- Control; 600 ml of water  
Blood Sample Collection 
Venous blood samples were obtained pre-exercise, immediately post-
exercise, 1-hour post-exercise, and 4 hours post-exercise. Samples sat at room 
temperature for 30-45 minutes to allow clotting. They were then centrifuged at 4°C 
for 15 minutes at 1500 rcf. The aliquoted serum was stored at -80°C until analysis. 
Furthermore, hematocrit was measured at each sample timepoint via HemoPoint® 
H2 Hemoglobin Meter (Stanbio Laboratory, Boerne, TX) to mathematically correct 
for changes in plasma volume. In addition to venous blood samples, finger stick 
blood samples were obtained pre-exercise and every 30 minutes post-exercise for 





automated glucose/lactate (YSI 2900 Series Analyzer, YSI Inc. Yellow Springs, 
OH). Plasma volume shifts are reported in Table 4.  
miRNA Isolation and Analysis 
Serum samples were thawed at room temperature and spun at 16,000 g for 
10 minutes at 4ºC. Total RNA was isolated from 50µL serum using the miRNeasy 
serum/plasma kit (Qiagen, Germantown, MD), with slight changes to the 
manufacturer’s protocol. The change involved using 50 µL serum samples with 
volumes of Qiazol lysis reagent and chloroform recommended for 200µL serum 
samples in attempt to improve RNA yield, as was previously reported (69). 
Specifically, serum was mixed with 20 volumes of Qiazol and 4 volumes of 
chloroform. A standard amount of synthetic spike-in control miR (C. elegans miR-
39) was added to all serum samples during isolation for assessment of recovery 
and calibration of PCR results. RNA was eluted in 14µL RNAse-free water. 
Reverse transcription was performed to generate cDNA from 10µL RNA using the 
miScript II RT Kit (Qiagen, Germantown, MD), and the product was diluted in 
200µL water. Real-time quantitative PCR was performed on an ABI 7300 Real-
Time PCR System (Applied Biosystems) using the miScript SYBR Green PCR Kit 
(Qiagen, Germantown, MD). Samples were assessed in duplicate using 2.5µL 
diluted cDNA. The levels of twelve a priori chosen miRNA (1, 21, 126, 133a, 146a, 
150, 206, 210, 221, 222, 486, 499a) were determined using specific primer assays 
(Qiagen). A disassociation curve analysis was performed to check for non-specific 
amplification. Further, those miRNA with CT values greater than 35 were 





presented as fold-changes relative to baseline with baseline set equal to 1. 
Expression values were compared using the 2-ΔΔCT method of relative 
quantification as previously described (70). For each miRNA, ΔCT was calculated 
as the CT of the miRNA of interest – CT of spike-in control miRNA. The ΔΔCT was 
determined as the ΔCT for an individual subject/time point –baseline ΔCT from the 
subject for the respective treatment.  
 
Statistical Analysis 
Raw ci-miRNA data were tested for normality via Shapiro-Wilk test. Since 
no ci-miRNA were normally distributed, raw data were log transformed and re-
assessed for normality. Any remaining non-normal data were adjusted for 
normality as described by Templeton (71). Once normality was established, Two-
way, repeated measures ANOVAs were conducted to determine a main effect for 
time. Comparisons were made between pre- and each post-exercise timepoint (i.e. 
post, post1hr, post4hr). Further, post hoc comparisons were made for changes in 
ci-miRNA across timepoints and between nutrition treatments using paired-
samples t-tests. Glucose values at the post1hr (1-hour post-exercise) timepoint 
were compared using paired-samples t-test. All statistical analysis was performed 
using Statistical Package for the Social Sciences (SPSS) Version 24 (IBM 









Heart rate responses and workloads during the exercise trials are reported 
in Table 2. Wingate power outputs are reported in Table 3.  
Circulating miRNA  
miRNA levels are expressed as fold changes relative to a baseline of 1 
(Figures 3-6). Three target miRNA (miR-133a, miR-206, and miR-499) were 
undetected in serum, and were excluded for analysis. Further, miR-1 was 
undetectable at baseline in one subject during the Pro trial, so this subject was 
excluded from analysis of miR-1. Additionally, miR-150 data for one subject were 
found to be an outlier (>2 SD) and were excluded from analysis.  
Skeletal Muscle miRNA; miR-1 & miR-486: 
 miR-1 was elevated above baseline at Post and Post-1 hr (main effect for 
time, p<0.05). Post hoc analysis revealed that miR-1 was elevated at post- and 
post-1 (p<0.05) with PLA. No nutritional effects were detected.  
miR-486 was increased above baseline at Post (main effect for time, 
p<0.01). Post hoc analysis revealed that miR-486 was not elevated at any 
timepoints post-exercise. Additionally, no nutritional effects were observed. 





miR-21 was upregulated at Post (main effect for time, p<0.01). Post hoc 
analysis showed that miR-21 was increased at post with PLA (p<0.05). No 
nutritional effects were observed. 
miR-126 was elevated at Post (main effect for time, p<0.01). Post hoc 
analysis demonstrated that miR-126 was increased at post with PLA and CHO 
(p<0.05). No nutritional effects were observed.  
miR-150 was upregulated at Post (main effect for time, p<0.01). Post hoc 
analysis showed that miR-150 was increased with CHO (p<0.05). Additionally, 
miR-150 demonstrated a nutritional effect at Post-1hr (main effect for treatment, 
p<0.01). Specifically, post hoc analysis revealed that PRO and CHO were 
decreased compared to PLA (p<0.05).  
miR-210 was enhanced at Post, Post-1 hr, and Post-4 hr (main effect for 
time, p<0.05). However, post hoc analysis revealed no changes from baseline 
post-exercise. No nutritional effects were observed.  
Inflammatory miRNA; miR-146a, miR-221, & miR-222: 
miR-146a was elevated at Post and Post-4 hr (main effect for time, p<0.01 
and p<0.05, respectively). Post hoc analysis demonstrated that mR-146a was 
increased with PLA and CHO (p<0.05) and was trending toward significance 
(p=0.05) with PRO at post1. No nutritional effects were observed.  
miR-221 was upregulated at Post (main effect for time, p<0.01). Post hoc 
analysis revealed that miR-221 was elevated at post by PLA (p<0.05) and CHO 





miR-222 was increased at Post (main effect for time, p<0.01). Post hoc 
analysis showed that miR-222 was increased at post by all treatments (p<0.01). 
No nutritional effects were observed.  
 
Blood Glucose Measurement 
Blood glucose was affected by CHO treatment at one-hour post-exercise, 

















Tables & Figures  
Table 1. Subject demographics 




21.9 ± 2.0 177.8 ± 6.8 78.5 ± 10.7 49.6 ± 4.0 300 ± 35.4 
 














Table 2. Interval workloads and heart rate responses 
 PLA PRO CHO 
Interval HR (bpm) Workload (W) HR (bpm) Workload (W) HR (bpm) Workload (W) 
1 177 ± 11 268 ± 33 177 ± 6 269 ± 31 175 ± 8 268 ± 26 
2 180 ± 9 247 ± 33 176 ± 12 251 ± 27 176 ± 8 241 ± 19 
3 179 ± 10 217 ± 29 176 ± 9 224 ± 27 173 ± 10 213 ± 29 
4 181 ± 10 212 ± 31 176 ± 10 210 ± 27 176 ± 9 212 ± 25 

















Table 3. Wingate power outputs 
PLA PRO CHO 
Wingate 1 (W) Wingate 2 (W) Wingate 1 (W) Wingate 2 (W) Wingate 1 (W) Wingate 2 (W) 
513 ± 93 458 ± 99 504 ± 82 458 ± 68 499 ± 94 463 ± 91 
 




















Table 4. Plasma Shift post-exercise (% change from baseline). Negative values represent plasma loss relative to baseline 
PLA PRO CHO 
Hct Post Hct Post1 HctPost4 Hct Post Hct Post1 HctPost4 Hct Post Hct Post1 HctPost4 
-13.5 ± 
11.0 





















 Pre Post Post-1 hr Post-4 hr 
PLA 76.6 ± 6.9 101.4 ± 16.0 69.0 ± 3.1* 76.1 ± 5.4 
PRO 87.1 ± 37.2 97.6 ± 19.5 69.4 ± 6.6* 76.0 ± 7.5 





Figure 1. Experimental Trial Design   
 
Visual schematic of exercise trial design (upper). Negative time-values denote time preceding the completion of the 








Figure 2A. Muscle-specific miRNA (miR-1) 
 





Figure 2B. Muscle-specific miRNA (miR-486) 
 





Figure 3A. Cardiovascular miRNA (miR-21) 
 





Figure 3B. Cardiovascular miRNA (miR-126) 
 





Figure 3C. Cardiovascular miRNA (miR-150) 
 
Circulating miRNA levels expressed as fold changes relative to baseline (Pre). * p<0.05; ## p<0.01 vs. baseline; ∆ p<0.01 





Figure 3D. Levels of circulating angiogenesis-associated miRNA (miR-210) 
 





Figure 4A. Inflammatory miRNA (miR-146a) 
  
Circulating miRNA levels expressed as fold changes relative to baseline (Pre). * p<0.05; + p=0.05; # p<0.05 vs. baseline; 





Figure 4B. Inflammatory miRNA (miR-221) 
 





Figure 4C. Inflammatory miRNA (miR-222) 
 






The primary objectives of this study were to examine the effects of high-
intensity cycling, along with different post-exercise nutritional treatments, on 
circulating levels of select miRNA. The primary finding was that high-intensity 
cycling altered all of the measured miRNA targets. This is in line with recent 
evidence that high-intensity exercise can affect ci-miRNA implicated in muscle and 
cardiovascular function (43, 72). This can now be extended to include miR-146a, 
miR-150, miR-210, miR-221, and miR-222. Surprisingly, post-exercise nutrition 
had no effect on ci-miRNA levels, with the exception of miR-150. This seems to 
suggest that phenoytype adaptations to high intensity training mediated by these 
target miRNA may not be accentuated by early post-exercise nutritional strategies. 
A note of caution should be made when interpreting any of the increases in 
immediate post-exercise levels, as the observed decrement in plasma volume shift 
(13-16%) (Table 4) at this timepoint almost certainly contributed to the increase in 
miRNA concentration.  
 The current findings are in general agreement with the scarce research on 
high-intensity exercise and ci-miRNA levels; however, the only targets that overlap 
between the current study and earlier reports are miR-1, miR-21, and miR-126. 
Specific to miR-1, the post-exercise increase in miR-1 reported by Cui et al. was 
not only confirmed here but we also found that miR-1 remains elevated for four 
hours post-exercise, particularly in the CHO condition (44). Interestingly, an earlier 
study by the Cui group demonstrated a downregulation of miR-1 post-exercise 





similar to the protocol used in the present study. When combined, it appears that 
miR-1 levels are largely upregulated following high-intensity exercise, though more 
work is needed to confirm this to determine whether there are specific exercise 
conditions that may have the opposite effect. Regarding targets -21 and -126, we 
report an increase in the endothelial miR-21 and miR-126, which is consistent with 
the findings of Wahl et al. using a nearly identical high-intensity exercise protocol 
(72). Interestingly, they observed higher magnitude changes in miR-21 and miR-
126 with other exercise protocols, such as their prolonged exercise (130 minutes 
at 55% Wmax) or sprint-interval exercise (4 x 30s all-outcompared to the protocol 
similar to our own (72), This may be due to greater sheer stress endured by the 
endothelial cells during severe exercise bouts, as previous research demonstrated 
that miR-21 is stimulated by shear stress (74).  
Muscle-specific miRNA: It has been documented that several myomiRs are 
found at very low levels in plasma, and may be difficult to detect in circulation (30). 
This was confirmed here, as , the only other myomiR detected at any timpepoint, 
besides miR-1, was miR-486. As mentioned above, our findings for miR-1 are in 
general agreement with previous reports. However, we are unaware of any 
previous studies examining the effects of high-intensity cycling on miR-486, and 
only one exercise study in general. In contrast to increase in immediate post-
exercise levels observed here, miR-486  has been shown to decrease in circulation 
following one hour of cycling at 70% VO2max (30). The reason for this discrepency 
is unclear, though it may be related to exercise intensity or duration, as the exercise 





miR-486 has been shown to target phosphatase and tensin homolog (PTEN), an 
established negative regulator of phosphoinositide-3-kinase (PI3K)/Akt signalling 
(76), implicating its potential to influence insulin signalling. Though purely 
speculative, if miR-486 does influence insulin signalling, then it may be beneficial 
to maintian or upregulate miR-486 during exercise in order to ensure adequate 
glucose uptake by exercising muscle. It may be that the exercise in the 
aformentioned study was of long enough duration and low enough intensity to 
allow for increased lipid utlization for energy, sparing glucose more and making 
maintenance of miR-486 during exercise less crucial for performance. 
Cardiovascular miRNA: The increase in both miR-21 and miR-126 (main 
effect) immediately post-exercise is in line with previous reports that miR-21 is 
elevated following a maximal exercise test (70) and miR-126 is higher following a 
maximal exercise test and throughout 4 hrs of cycling (27). Mechanistically, as 
previously mentioned, the increase in miR-21 may be due to the shear stress 
experienced by the endothelium during heavy exercise (74) and may ultimately 
faciitate angiogenesis (77) whereas the upregulation of miR-126 was likely 
triggered by the hypoxic stress induced by the prolonged cycling and can enhance 
pro-angiogenic factors, such as VEGF (78). Both miR-21 and miR-126 are critical 
for vascular function, as miR-21 was shown to decrease endothelial apoptosis and 
stimulate the nitric oxide (NO) production pathway in order to produce favorable 
vascular responses to shear stress (74). Alternatively,, miR-126 was vital for 





has resulted in reduced vascular integrity, leading to vascular leakage and 
hemmorhage (78). 
 Additionally, miR-150 was upregulated following a 10-km race (28) and 
after training in mice(79). There is limited data concerning the effects of exercise 
on miR-150, as it is more commonly examined in disease states (80, 81). However, 
miR-150 may produce positive cardiovascular effects, as it was shown to protect 
the heart from injury in mouse MI models (82) and inibit foam cell formation in vitro 
(83). 
The angiogenesis-related miRNA assessed in this project, miR-210, was 
increased throughout the post-exercise period in the current study. This finding 
contradicts a similar finding by Baggish et al. who reported no change in miR-210 
following a maximal exercise test (70). Additionally, miR-210 was not affected by 
resistance exercise (84). Interestingly, overexpression of miR-21 has been shown 
to induce HIF-1α in human prostate cancer cells (77) and miR-210 is both induced 
by, and critical in response to, by hypoxia (85). It has been demonstrated that HIF 
signalling can induce miR-210 (82), illustrating a possible integrative miRNA 
signalling network in response to hypoxic conditions. It is possible that the 
previously mentioned exercise stimuli failed to induce hypoxia to the extent that 
the current exercise protocol did, and, as a result, did not increase miR-210 as 
presently observed.  
Inflammation-implicated miRNA: miR-146a, -221, and -222, targets 
associated with inflammation (86–88), were increased immediately post-exercise 





hour post-exercise, a main effect for time was detected at four-hours post-exercise 
for miR-146a. To our knowledge, miR-146a levels have not been examined 
following high-intensity exercise. Though it has been shown to increase in 
circulation following a maximal exercise test, it was decreased following one hour 
of cycling at 65% of maximal power output (89). While Baggish et al. reported a 
similar, if not greater, fold-increase in ci-miR-146a following a marathon than as 
we reported (67), de Gonzalo-Calvo et al. reported no change in miR-146a levels 
from baseline following a marathon (28). Interestingly, neither of the 
aforementioned studies followed the same blood sampling timecourse as the 
current study. Baggish et al. collected post-exercise blood samples immediately 
and 24 hours post-exercise (67), so if miR-146a has any fluctuation in its post-
exercise timecourse, the collectoin timepoints may have been too far apart to 
capture it. Similarly to previous work (70), miR-221 and -222 were elevated 
immediately post-exercise in the present study. miR-221 and miR-222 appear to 
regulate vascular function, as miR-221 overexpression was shown to inhibit 
adiponectin-derived nitric oxide (NO) production (87) and both miRNA work 
together to regulate cell apoptosis (58).  
Perhaps the most surprising finding of this study was that nutrition had no 
influence on ci-miR levels following high-intensity cycling except for miR-150, 
though it is not yet known what functional significance this finding may have. Few 
studies have examined the role of nutrition on ci-miRNA levels, and even fewer 
have explored the effects of combining nutrition with exercise. Importantly, to our 





nutrition on miRNA activity chose to investigate intramuscular mi-RNA, not 
circulating levels. It is not clear to what extent ci-miRNA profiles reflect 
intramuscular miRNA activity, so the results of previous biopsy studies may be 
difficult to translate to ci-miRNA research. Regardless, while the present study 
observed no effects of nutrition or exercise on ci-miR-486, Camera et al. 
demonstrated that protein intake following concurrent exercise lead to greater 
levels of miR-486 four hours post-exercise (51). Drummond et al. have also shown 
that nutrition, without an exercise stimulus, can increase miRNA in skeletal muscle 
(50). One of the unique features of this study was the inclusion of CHO as a 
nutrition treatment, independent of PRO. To our knowledge, only one study has 
used CHO as a nutrition treatment to examine its effects on miRNA activity, and it 
was combined with PRO instead of being administered alone. Margolis et al. 
provided subjects with a PRO/CHO beverage during 90 min of cycling and 
weighted load carriage sessions. They reported that nutrient provision 
downregulated miR-1 compared to placebo, and the decrease was more apparent 
in the weighted exercise mode (73). The authors speculated that their findings may 
be explained in part by modulations in muscle protein synthesis by the combined 
mechanical strain of the exercise (especially the weighted carriage) and nutrition 
consumption (73). Altogether, more research is needed to establish nutrition 
strategies that may be used, with or without exercise, to manipulate miRNA activity 
to obtain favorable adaptations for health or performance.  





Altogether, high-intensity cycling was found to alter several ci-miRNA 
profiles while post-exercise nutrition had very little impact. Given the relatively new 
research interest in miRNA response to exercise, more research is needed to 
further our understanding of how exercise impacts miRNA and how these impacts 
may be used to illucidate the molecular underpinning of adaptations to acute and 
chronic exercise. Considering the widespread influence of miRNA on exercise 
response and physiological function, more research is needed to examine the 
potential use of miRNA for pharmocological modification in order to modify disease 
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James Madison University 
Department of Kinesiology 
Consent for Investigative Procedure 
 
I, ______________________, hereby agree on _____________ (date) to 
participate in the research project conducted by Nicholas D. Luden, Ph.D. and 
Jeremy Via from James Madison University titled Circulating MicroRNA Following 
High Intensity Interval Cycling With and Without Post-Exercise Nutrient 
Consumption. 
The purpose of this study is to examine the effects of high intensity interval cycling 
and post-exercise nutrient composition on circulating miRNA profile. Furthermore, 
this study aims to examine correlations between blood glucose levels and 




I understand that I will undergo the following testing: 
 
This study consists of 4 separate visits performed, all of which will involve exercise 
on a stationary bike (cardiovascular fitness test and three exercise trials). All 
testing will occur in Godwin Hall, room 209, on the campus of James Madison 
University. You will also be asked about lifestyle behaviors such as smoking and 
physical activity and complete dietary and physical activity records. The total time 
commitment is estimated to be less than 8 hours over the course of 4 weeks. 
 
Preliminary Trial (1 visit; 60 min):  
 
After completing this consent form and the health status screening, if you meet the 







You will then be asked to perform a maximal cardiovascular fitness test to 
determine your maximum oxygen consumption (VO2max). You will be asked to 
ride a stationary bike at an initial workload that is ‘fairly easy’. The workload will 
then be increased every two minutes until fatigue is reached, determined by either: 
1) your request to stop due to fatigue, or 2) inability to maintain a cadence of ≥50 
revolutions per minute. You will be verbally encouraged to continue to obtain an 
accurate measurement of VO2max. To access oxygen consumption, you will need 
to breathe through a mouthpiece/breathing apparatus which collects expired air 
throughout the test (10-15 minutes). Heart rate and rate of perceived exertion 




Exercise Trial (3, 60 min each) 
 
You will be asked to arrive at the human performance lab between 7-9am, 
following an overnight fast and not having consumed alcohol or tobacco 24 hrs or 
caffeine 12 hrs prior to testing.  
 
Blood Sampling – Before beginning the exercise protocols, a resting blood sample 
will be acquired via venous blood draw. ≤4mL will be obtained for each sample. 
Furthermore, venous blood samples will be obtained immediately post-exercise, 
1-hour post-exercise, and 4 hours post-exercise. Finger stick blood samples will 
also be collected pre-exercise, immediately post-exercise, and every 30 minutes 
following exercise for 4 hours. Samples will be between 20-60µL. 
 
Exercise Protocol – Following a 5-minute warm-up at 50W, you will be asked to 
perform a cycling exercise protocol consisting of: a 30-second, maximum effort 
sprint (Wingate test), followed by 4x3 minutes at 90% Wmax, and concluding with 
a second Wingate test. Heart rate will be measured and recorded during each 
stage via heart rate monitor. A 5-minute cooldown will be performed upon 




Upon completion of the exercise protocols in each exercise trial, you will be given 
a nutrition beverage containing either: placebo, carbohydrate (CHO), or a 





and double-blinded. You must consume the beverage within 30 minutes of 
completing the exercise. 
  
Dietary and Exercise Controls: 
 
You will be asked to record all food and beverage intake for 24 hrs preceding the 
exercise trials. After the initial exercise trial, you will be provided with copies of 
your dietary records and instructed to replicate their dietary habits for the following 
exercise trials. You will be asked to report to all testing after an overnight fast. You 
will be asked to consume the nutrition beverage within 30 minutes of completing 
the exercise trial, and the time taken to consume the beverage should be 
consistent across all trials. Additionally, you will be instructed to refrain from 
consuming anything other than water during the 4 hours following the trial. You will 
be given a small, standardized meal 2 hours following completion of the exercise 
(90 minutes following the consumption of the nutrition beverage). You will also be 
instructed to record all physical activity 72 hrs prior to the first exercise trial. 
Additionally, you will be instructed to avoid physical activity between the post-
exercise blood samples, and to keep physical activity habits consistent between 




Cardiovascular Exercise (Wingate Test, Intervals, and VO2max test) 
 
According to the American College of Sports Medicine’s Guidelines for Exercise 
Testing and Prescription, people without signs, symptoms, or diagnosis of 
cardiovascular, metabolic, or renal disease are cleared for vigorous exercise.  The 
conditions that the exercise sessions are to take place are likely safer than the 
typical exercise environments of the subjects. If you do not meet ACSM criteria of 
clearance for vigorous exercise, you will not be allowed to participate in the study. 
In the unlikely event of cardiac or other complications during exercise, an 
emergency plan is in place. This includes immediate access to a phone to call 
emergency personnel. In addition, at least one of the listed investigators will be 




The risks of blood sampling using venous blood sampling or finger stick technique 





as well as possible risks of infection or skin irritation.  These risks are considered 
to be minimal, and all safety precautions for handing blood samples will be followed 
according to OSHA protocols, including: investigators will wear latex gloves at all 
times during blood sampling and testing. A sharps container lined with a biohazard 
bag will be used for all sharp objects involved in the blood sampling; all other 
materials (i.e. gloves, gauze pads, etc.) used during the sampling will be put in a 
separate waste disposal unit lined with a biohazard bag. All investigators who will 
be involved in blood draws (and handling of blood) have been trained in these 
phlebotomy techniques, and completed JMU blood-borne pathogen training. 
Additional risks include injury to blood vessels, as well as dizziness, vasovagal 
syncope (fainting), and nausea. A total of <100 milliliters of blood will be obtained 
throughout the course of the study, which is roughly 21% of the amount of blood 
typically obtained during blood donation (1 pint or 473 milliliters). 
 
Benefits: 
Upon request, you will receive your cardiovascular fitness testing results. If you 
compete the project, you will be given a free Human Performance Laboratory t-
shirt and entered into a lottery to win $150. 
 
Confidentiality: 
The results of this research will be presented at conferences and published in 
exercise science journals.  The results of this project will be coded in such a way 
that your identity will not be attached to the final form of this study.  The researcher 
retains the right to use and publish non-identifiable data.  However, you can ask 
that your data be removed from the study at any point prior to presentation and 
publication.  While individual responses are confidential, aggregate data will be 
presented representing averages or generalizations about the responses as a 
whole.  All data will be stored in a secure location accessible only to the researcher.  
Final aggregate results will be made available to you upon request. 
 
Participation & Withdrawal: 
Your participation is entirely voluntary.  You are free to choose not to participate.  
Should you choose to participate, you can withdraw at any time without 
consequences of any kind.  Your right to withdraw includes the right to request that 
your blood samples be discarded at any time. To dispose of your samples, your 
samples will be rinsed down a chemical drain in our laboratory or will be disposed 
of in a biohazard container. Again, your sample will not be identifiable without the 








You may have questions or concerns during the time of your participation in this 
study, or after its completion.  If you have any questions about the study, contact 
Nicholas D. Luden, Ph.D. at ludennd@jmu.edu or by phone at 540-568-4068. 
 
Giving of Consent: 
I have read this consent form and I understand what is being requested of me as 
a participant in this study.  I freely consent to participate.  I have been given 
satisfactory answers to my questions.  The investigator provided me with a copy 
of this form.  I certify that I am at least 18 years of age. 
 
   
Name of Participant  (Printed)  Name of Researcher(s)  (Printed) 
   
Name of Participant  (Signed)  Name of Researcher(s)  (Signed) 
   
  Date        Date 
 
For questions about your rights as a research subject, you may contact the chair 
































24-HOUR DIET RECORD 
 
Subject number____________  Date______________ Day of Week______________ 
 
 
Time Food and/or Drink Method of Preparation Quantity Consumed Brand Name 
     
     
     
     
     
     
     
     
     
     
 






Physical Activity Records 
 
Subject #    Trial #
    Date:
   
 
Date 







(use scale below) 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 












7 Very, very light 
8 
9 Very light 
10 
11 Fairly light 
12 




17 Very hard 
18 
















Typical Exercise Habits over the Past 3-6 Months: 
 
Average number of days of aerobic exercise per week     
 
Average number of hours of aerobic exercise per week    
 
Briefly describe your aerobic exercise habits over the past 3-6 months: 
 
 
Average number of days of resistance exercise/weight lifting per week _____________ 
 
Average number of hours of resistance exercise/weight lifting per week _____________ 
 
Briefly describe your resistance training habits over the past 3-6 months: 
 
 
Do you have a muscle or joint injury/condition that precludes the completion of the 
exercise protocol? If yes, please explain. 
 
 
Are you allergic to wheat? 
 
Do you have gluten intolerance? 
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